Hangzhou Coco Healthcare Products Co.,Ltd. (SHE:301009)
7.20
-0.41 (-5.39%)
Nov 20, 2026, 3:04 PM CST
SHE:301009 Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Revenue Revenue Growth | 1,226 | 1,150 | 1,079 | 1,081 | 1,186 | 1,186 |
Revenue Growth | 9.61% | 6.65% | -0.27% | -8.83% | -0.01% | -27.44% |
Gross Profit Gross Profit Growth | 276.62 | 265.04 | 211.84 | 181.22 | 143.63 | 213.25 |
Operating Income Operating Income Growth | 4.45 | 22.37 | 1.88 | 3.97 | -41.21 | 33.92 |
Net Income Net Income Growth | -5.09 | 36.12 | 31.17 | 20.18 | -43.13 | 39.75 |
Earnings Per Share EPS Growth | -0.02 | 0.14 | 0.12 | 0.07 | -0.16 | 0.17 |
EPS Growth | - | 16.67% | 71.43% | - | - | -83.81% |
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
China China Growth | 715.28 | 625.92 | 609.71 | 587.17 | 604.4 |
Overseas Overseas Growth | 434.95 | 452.61 | 471.77 | 599.12 | 582 |
Total Total Growth | 1,150 | 1,079 | 1,081 | 1,186 | 1,186 |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash & Investments Cash & Investments Growth | 916.31 | 1,002 | 863.75 | 863.06 | 689.46 | 884.04 |
Total Debt Total Debt Growth | 268.71 | 209.06 | 112.01 | 18.05 | 4.64 | 6.61 |
Net Cash (Debt) Net Cash Growth | 647.6 | 793.02 | 751.74 | 845.01 | 684.82 | 877.44 |
Net Cash Growth | -16.58% | 5.49% | -11.04% | 23.39% | -21.95% | 143.68% |
Net Cash Per Share Net Cash Per Share Growth | 2.51 | 3.07 | 2.89 | 2.93 | 2.54 | 3.75 |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 59.33 | 126.76 | 52.44 | 227.7 | -37.2 | 50.53 |
Capital Expenditures CapEx Growth | -105.95 | -39.88 | -75.35 | -66.01 | -116.4 | -240.45 |
Free Cash Flow Free Cash Flow Growth | -46.62 | 86.88 | -22.91 | 161.69 | -153.6 | -189.92 |
Free Cash Flow Growth | - | - | - | - | - | - |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Gross Margin | 22.55% | 23.04% | 19.64% | 16.76% | 12.11% | 17.97% |
Operating Margin | 0.36% | 1.94% | 0.18% | 0.37% | -3.47% | 2.86% |
Pretax Margin | -0.73% | 3.42% | 3.05% | 1.80% | -4.75% | 3.67% |
Profit Margin | -0.41% | 3.14% | 2.89% | 1.87% | -3.64% | 3.35% |
FCF Margin | -3.80% | 7.55% | -2.12% | 14.95% | -12.95% | -16.01% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Nov '26 Nov 21, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Dividend Per Share Dividend Per Share Growth | 0.120 | 0.120 | 0.070 | 0.075 | - | 0.070 |
Dividend Per Share Growth | 71.43% | 71.43% | -6.67% | - | - | - |
Dividend Yield | 1.67% | 0.95% | 0.66% | 0.70% | - | 0.38% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Nov '26 Nov 21, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
PE Ratio | - | 93.53 | 91.36 | 143.57 | - | 126.20 |
Forward PE | - | 97.54 | 92.96 | 29.61 | 39.34 | 27.44 |
P/FCF Ratio | - | 38.89 | - | 17.92 | - | - |
PS Ratio | 1.56 | 2.94 | 2.64 | 2.68 | 2.75 | 4.23 |